Alain Rivard
Impact in
- Cancer Research top 5%
- Cancer, Hypoxia, and Metabolism
- Genetics top 5%
- Mesenchymal stem cell research
Papers in
-
- MicroRNA in disease regulation 10
- Cancer-related molecular mechanisms research 6
-
- Eicosanoids and Hypertension Pharmacology 7
- Co-authors
- Jeffrey M. IsnerMarianne KearneyMeredith MagnerSylvie DussaultDongfen ChenMarcy SilverPaola HaddadJessika Groleau
- Journals
- Atherosclerosis (10 papers)Circulation (6 papers)Arteriosclerosis Thrombosis and Vascular Biology (5 papers)Human Gene Therapy (2 papers)Gene Therapy (2 papers)
- Partner nations
- CanadaUnited StatesFrance
In The Last Decade
Alain Rivard
54 papers receiving 3.4k citations
Hit Papers
Peers
Comparison fields: 5 of 112
- Cancer Research 589
- Genetics 321
- Molecular Biology 2.1k
- Cardiology and Cardiovascular Medicine 625
- Biochemistry 164
Countries citing papers authored by Alain Rivard
This map shows the geographic impact of Alain Rivard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alain Rivard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alain Rivard more than expected).
Fields of papers citing papers by Alain Rivard
This network shows the impact of papers produced by Alain Rivard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alain Rivard. The network helps show where Alain Rivard may publish in the future.
Co-authors
The 25 scholars most cited alongside Alain Rivard, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 0 | |
| 3 | 2023 | 2 | |
| 4 | 2023 | 6 | |
| 5 | 2020 | 3 | |
| 6 | 2020 | 18 | |
| 7 | 2020 | 4 | |
| 8 | 2016 | 30 | |
| 9 | Abstract 16010: Reduced Expression of miR-130a-3p Contributes to Endothelial Cell Senescence and Age-dependent Impairment of Neovascularization | 2016 | 1 |
| 10 | 2015 | 10 | |
| 11 | 2015 | 6 | |
| 12 | 2014 | 11 | |
| 13 | 2014 | 1 | |
| 14 | 2009 | 21 | |
| 15 | 2006 | 194 | |
| 16 | 2006 | 96 | |
| 17 | 2000 | 48 | |
| 18 | 1999 | 380 | |
| 19 | 1998 | 24 | |
| 20 | 1998 | 1 |
About Alain Rivard
Alain Rivard is a scholar working on Cancer Research, Biochemistry, Molecular Biology, Genetics and Internal Medicine, having authored 56 papers that have together received 3.5k indexed citations. Recurring topics across this work include Angiogenesis and VEGF in Cancer (29 papers), MicroRNA in disease regulation (10 papers), Coronary Interventions and Diagnostics (10 papers), Eicosanoids and Hypertension Pharmacology (7 papers), Nitric Oxide and Endothelin Effects (6 papers), Cancer-related molecular mechanisms research (6 papers), Neutrophil, Myeloperoxidase and Oxidative Mechanisms (5 papers) and Mesenchymal stem cell research (5 papers). The work is most often cited by research in Cancer Research (589 citations), Genetics (321 citations), Molecular Biology (2.1k citations), Cardiology and Cardiovascular Medicine (625 citations) and Biochemistry (164 citations). Alain Rivard has collaborated with scholars based in Canada, United States and France. Frequent co-authors include Jeffrey M. Isner, Marianne Kearney, Meredith Magner, Sylvie Dussault, Dongfen Chen, Marcy Silver, Paola Haddad, Jessika Groleau, J Fabre and Catherine Ménard. Their work appears in journals such as Atherosclerosis, Circulation, Arteriosclerosis Thrombosis and Vascular Biology, Human Gene Therapy and Gene Therapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.